Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

The new version of syngo.via supports treatment decision-making in oncology

17.06.2015
  • Diagnostics software supports informed treatment decision-making and comprehensive treatment planning by compiling information from different imaging modalities
  • Early checking of treatment by means of a quantitative evaluation of the success of the treatment
  • Offline functionality for the interdisciplinary exchange of information


Cancer treatment is complex. The widely varying progressions of this disease require comprehensive diagnostics, an early check of treatment, and the exchange of information with colleagues. The new version of the diagnostics software syngo.via supports the treating physician in making decisions regarding treatment in oncology through a comprehensive portfolio of applications across imaging systems, treatments, and disciplines.


The new syngo.via – easier than ever

Discover a whole new user experience with syngo.via. You will love the refreshed look and feel and the intuitive operation. Also new: a Google-like search with the Patient Browser.


Imaging procedures play an important role in treatment planning. Multimodal image material not only provides information for a precise assessment of the tumor with regard to its position, morphology and metabolism, but it also forms the basis for radiotherapy planning. The application syngo.via RT Image Suite supports the radiotherapy oncologists in the demanding task of optimally using clinical images from various sources such as CT, MRT or PET-CT in order to contour the tumor to be irradiated and the surrounding tissue to be spared.

Another part of the oncology software portfolio is the application syngo.MR OncoCare. It allows an early, quantitative evaluation of the response of the tumor to the treatment. Thus, conclusions can be drawn about the success of the selected treatment method and, if necessary, this method can be adapted. Thus, the patient is spared from the continuation of ineffective treatment and the unnecessary costs associated with it.

In order to define the best possible treatment for each individual patient and successfully treat cancer, a wide variety of medical disciplines are drawn upon. Their representatives come together in regular, interdisciplinary meetings on this topic in so-called tumor boards. Syngo.MI Offline Oncoboard provides an IT solution in order to be able to present syngo.via findings of the various imaging procedures even on a standard PC and independently of a network connection.

syngo.via can be used as a standalone device or together with a variety of syngo.via-based software options, which are medical devices in their own right. syngo.via and the syngo.via based software options are not commercially available in all countries. Due to regulatory reasons its future availability cannot be guaranteed. Please contact your local Siemens organization for further details.

You can find further information under www.siemens.com/syngo.via


Siemens AG (Berlin and Munich) is a global technology powerhouse that has stood for engineering excellence, innovation, quality, reliability and internationality for more than 165 years. The company is active in more than 200 countries, focusing on the areas of electrification, automation and digitalization. One of the world's largest producers of energy-efficient, resource-saving technologies, Siemens is No. 1 in offshore wind turbine construction, a leading supplier of combined cycle turbines for power generation, a major provider of power transmission solutions and a pioneer in infrastructure solutions as well as automation, drive and software solutions for industry. The company is also a leading provider of medical imaging equipment – such as computed tomography and magnetic resonance imaging systems – and a leader in laboratory diagnostics as well as clinical IT. In fiscal 2014, which ended on September 30, 2014, Siemens generated revenue from continuing operations of €71.9 billion and net income of €5.5 billion. At the end of September 2014, the company had around 357,000 employees worldwide on a continuing basis.

Further information is available on the Internet at www.siemens.com


Reference Number: PR2015060254HCEN


Contact
Mr. Thorsten Opderbeck
Healthcare
Siemens AG

Henkestr. 127

91052 Erlangen

Germany

Tel: +49 (9131) 84-4906

thorsten.opderbeck​@siemens.com

Thorsten Opderbeck | Siemens Healthcare

More articles from Medical Engineering:

nachricht Biocompatible 3-D tracking system has potential to improve robot-assisted surgery
17.02.2017 | Children's National Health System

nachricht Real-time MRI analysis powered by supercomputers
17.02.2017 | University of Texas at Austin, Texas Advanced Computing Center

All articles from Medical Engineering >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Breakthrough with a chain of gold atoms

In the field of nanoscience, an international team of physicists with participants from Konstanz has achieved a breakthrough in understanding heat transport

In the field of nanoscience, an international team of physicists with participants from Konstanz has achieved a breakthrough in understanding heat transport

Im Focus: DNA repair: a new letter in the cell alphabet

Results reveal how discoveries may be hidden in scientific “blind spots”

Cells need to repair damaged DNA in our genes to prevent the development of cancer and other diseases. Our cells therefore activate and send “repair-proteins”...

Im Focus: Dresdner scientists print tomorrow’s world

The Fraunhofer IWS Dresden and Technische Universität Dresden inaugurated their jointly operated Center for Additive Manufacturing Dresden (AMCD) with a festive ceremony on February 7, 2017. Scientists from various disciplines perform research on materials, additive manufacturing processes and innovative technologies, which build up components in a layer by layer process. This technology opens up new horizons for component design and combinations of functions. For example during fabrication, electrical conductors and sensors are already able to be additively manufactured into components. They provide information about stress conditions of a product during operation.

The 3D-printing technology, or additive manufacturing as it is often called, has long made the step out of scientific research laboratories into industrial...

Im Focus: Mimicking nature's cellular architectures via 3-D printing

Research offers new level of control over the structure of 3-D printed materials

Nature does amazing things with limited design materials. Grass, for example, can support its own weight, resist strong wind loads, and recover after being...

Im Focus: Three Magnetic States for Each Hole

Nanometer-scale magnetic perforated grids could create new possibilities for computing. Together with international colleagues, scientists from the Helmholtz Zentrum Dresden-Rossendorf (HZDR) have shown how a cobalt grid can be reliably programmed at room temperature. In addition they discovered that for every hole ("antidot") three magnetic states can be configured. The results have been published in the journal "Scientific Reports".

Physicist Dr. Rantej Bali from the HZDR, together with scientists from Singapore and Australia, designed a special grid structure in a thin layer of cobalt in...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Booth and panel discussion – The Lindau Nobel Laureate Meetings at the AAAS 2017 Annual Meeting

13.02.2017 | Event News

Complex Loading versus Hidden Reserves

10.02.2017 | Event News

International Conference on Crystal Growth in Freiburg

09.02.2017 | Event News

 
Latest News

Switched-on DNA

20.02.2017 | Materials Sciences

Second cause of hidden hearing loss identified

20.02.2017 | Health and Medicine

Prospect for more effective treatment of nerve pain

20.02.2017 | Health and Medicine

VideoLinks
B2B-VideoLinks
More VideoLinks >>>